Day: August 27, 2020

MONTRÉAL, 27 août 2020 (GLOBE NEWSWIRE) — Le CN (TSX : CNR) (NYSE : CNI) est heureux d’annoncer l’octroi d’un contrat pour la construction de 1 150 wagons-trémies à céréales de grande capacité et de nouvelle génération à National Steel Car Ltd. de Hamilton en Ontario. Cette commande porte à 1 G$ le montant que le CN prévoit investir en Ontario d’ici la fin de 2022.Outre son acquisition de 1 150 wagons et ses investissements stratégiques annuels en infrastructures, le CN a également annoncé un investissement de plus de 250 M$ dans la construction du projet de centre logistique de Milton, une infrastructure de transport essentielle pour l’avenir économique des consommateurs en Ontario et au Canada.Le 21 juillet 2020, le CN a annoncé l’acquisition de nouveau wagons-trémies à céréales fermés de 55 pieds et huit pouces, ayant une capacité...

Hagnaður af starfsemi RARIK nam 424 milljónum króna á fyrri helmingi ársins, sem er um 66% lækkun á milli ára.Rekstrarhagnaður af starfsemi RARIK fyrir fjármagnsliði (EBIT) á fyrri hluta ársins 2020 var 1.039 milljónir króna en var 1.616 milljónir króna á fyrri helmingi ársins 2019. Rekstrartekjur lækkuðu um 2,3% miðað fyrra ár og rekstrargjöld með afskriftum hækkuðu um 5,7% og voru hærri en áætlanir gerðu ráð fyrir vegna mikilla tjóna í ársbyrjun.Fjármagnsliðir voru neikvæðir um 1.014 milljónir króna á tímabilinu, samanborið við 735 milljónir króna fyrri hluta ársins 2019. Hækkunin skýrist aðallega af gengisbreytingum.Áhrif hlutdeildarfélagsins Landsnets voru jákvæð um 404 milljónir króna, samanborið við 538 milljónir króna á fyrri hluta síðasta árs.Samkvæmt rekstrarreikningi var hagnaður á tímabilinu 424 milljónir króna samanborið við...

An Emerging Markets Sponsored CommentaryORLANDO, Fla., Aug. 27, 2020 (GLOBE NEWSWIRE) — Of late, there has been a bounty of good news issued by Biotricity (OTCQB: BTCY) whose remote medical monitoring systems have experienced expanded interest. Biotricity’s technology, you may recall, enables patients to provide health care providers with critical health data from their homes.We believe that enthusiasm by patients and health care providers for remote health care is a trend since it simply does not make sense to expose someone who may or may not have health issues into a facility full of patients under similar circumstances when a monitor can provide the same information available during an in-office visit. Not every in-office visit can be replaced by remote medicine but many can.Along these lines, Biotricity added to its remote...

Not for distribution by US newswire or in United StatesNESS-ZIONA, Israel, Aug. 27, 2020 (GLOBE NEWSWIRE) — VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases, would like to provide an update on the following:On July 20, 2020, the Company announced the commencement of the in vivo (animal) study for Vaxil’s COVID-19 vaccine candidate (Corvax™), under the guidance of Dr. Hagin, Director of the Allergy and Clinical Immunology Unit at the Tel Aviv Medical Center. The experiment was designed to evaluate the immune response to Vaxil’s Corvax™ and was commenced with the first animal injection administered on July 14, 2020.Over the last few weeks, Corvax™ injections were administered and are now complete. The Company is now proceeding to...

Sjá viðhengi:ViðhengiUrsus flöggun 27 08 2020pdf (002)

Not for Distribution to United States Newswire Services or for dissemination in the United StatesVANCOUVER, British Columbia, Aug. 27, 2020 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO) is pleased to announce that it has closed its previously announced and increased brokered and concurrent non-brokered private placements of subscription receipts (“Subscription Receipts”) of the Company to raise gross proceeds of approximately C$56 million (collectively, the “Offering”). The Offering was undertaken in conjunction with Novo’s planned acquisition of Millennium Minerals Limited (the “Acquisition”) (please refer to the Company’s news releases dated August 4, 2020, August 5, 2020, and August 11, 2020 for further details).Gross proceeds of approximately C$51 million were raised from the brokered private...

MCLEAN, Va., Aug. 27, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing that the 30-year fixed-rate mortgage (FRM) averaged 2.91 percent.“This year has been anything but normal and as the uncertainty lingers, mortgage rates remain near record lows,” said Sam Khater, Freddie Mac’s Chief Economist. “These rates continue to incentivize potential buyers and the home buying season, which shifted from spring to summer, will likely continue into the fall.”News Facts30-year fixed-rate mortgage averaged 2.91 percent with an average 0.8 point for the week ending August 27, 2020, down from last week when it averaged 2.99 percent. A year ago at this time, the 30-year FRM averaged 3.58 percent.  15-year fixed-rate mortgage averaged 2.46 percent with an average...

HOUSTON, Aug. 27, 2020 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting cancers caused by dysregulated gene expression, announced today that its Chief Executive Officer, David Arthur, will present during the 2020 LD 500 Conference. The event will take place September 1-4, 2020 via a virtual technology platform.Mr. Arthur will present an overview of Salarius’ business and highlight its recent corporate and clinical achievements, as well as the anticipated milestones in its clinical program for its lead compound, seclidemstat. Seclidemstat is a reversible LSD1 inhibitor now undergoing two Phase 1/2 clinical trials in Ewing sarcoma, a rare and deadly pediatric bone cancer, and advanced solid tumors (AST). Members of the Salarius management team will be available to participate...